Proteome Sciences shares rise 10% after swing to interim profit
(Alliance News) - Proteome Sciences PLC on Thursday said it swung to an interim profit in the first half of 2022 on the strength of its TMT reagents.
Read moreMon, 31st Dec 2012 12:50
(Alliance News) - Proteome Sciences PLC on Thursday said it swung to an interim profit in the first half of 2022 on the strength of its TMT reagents.
Read more(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:
Read more(Sharecast News) - Proteome Sciences has completed its next milestone towards the launch of 'single cell proteomics' services, it announced on Wednesday, dubbed 'SysQuant SCP'.
Read more(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:
Read more(Sharecast News) - Proteome Sciences said in an update on Monday that it had maintained a strong order book after recording a small profit in 2021.
Read moreProteome Sciences PLC - Drug development services provider - Secures a contract from major US academic group to evaluate changes on the proteome and phospho-proteome of tissue and blood samples taken from people with and without a neurodegenerative disease. The contract's value exceeds GBP500,000. Proteome refers to entire set of proteins in a cell or organism.
Read more(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.
Read more(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Thursday and Friday and not separately reported by Alliance News:
Read more(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:
Read moreProteome Sciences PLC - drug development services provider - Amends GBP1 million loan with Vulpes Investment Management Private Ltd, which was signed in the summer of 2018. Accrued interest now repayable on June 30, 2023, extended from May 1, 2022. Notes GBP700,000 is currently drawn on facility.
Read moreWednesday 30 March | |
Anglo Pacific Group PLC | Full Year Results |
Bank of Cyprus Holdings PLC | Full Year Results |
Bowleven PLC | Half Year Results |
Canadian Overseas Petroleum Ltd | Full Year Results |
Ebiquity PLC | Full Year Results |
Equals Group PLC | Full Year Results |
Gulf Keystone Petroleum Ltd | Full Year Results |
Inspired PLC | Full Year Results |
Keywords Studios PLC | Full Year Results |
Michelmersh Brick Holdings PLC | Full Year Results |
Shepherd Neame Ltd | Half Year Results |
Team17 Group PLC | Full Year Results |
Thursday 31 March | |
Eleco PLC | Full Year Results |
BBGI Global Infrastrcture SA | Full Year Results |
Chesnara PLC | Full Year Results |
Gattaca PLC | Half Year Results |
Hostelworld Group PLC | Full Year Results |
James Halstead PLC | Half Year Results |
Mears Group PLC | Full Year Results |
Record PLC | Full Year Results |
RTW Venture Fund Ltd | Full Year Results |
S4 Capital PLC | Full Year Results |
Sportech PLC | Full Year Results |
Proteome Sciences PLC | Full Year Results |
Provident Financial PLC | Full Year Results |
Friday 1 April | |
HydrogenOne Capital Growth PLC | Full Year Results |
Renew Holdings PLC | Trading Statement |
Medica Group PLC | Full Year Results |
Monday 4 April | |
CentralNic Group PLC | Full Year Results |
Elixirr International PLC | Full Year Results |
Xpediator PLC | Full Year Results |
Tuesday 5 April | |
DP Eurasia NV | Full Year Results |
Homeserve PLC | Trading Statement |
Moonpig Group PLC | Trading Statement |
Next Fifteen Communications Group PLC | Full Year Results |
Quixant PLC | Full Year Results |
SourceBio International PLC | Full Year Results |
Copyright 2022 Alliance News Limited. All Rights Reserved. |
TRADING UPDATES: Alliance Pharma to appeal; Braemar sales to rise
Read moreAIM WINNERS & LOSERS: Fundraise lifts ImmuPharma; Proteome wins deal
Read moreProteome Sciences shares climb on GBP1 million contract win
Read more(Sharecast News) - Proteomics and biomarker research firm Proteome Sciences has secured a contract valued at more than £1.0m from an unnamed major pharmaceutical company.
Read more